Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Scaglia F, Longo N
There is insufficient evidence to suggest that nucleoside analogs used in the treatment of HIV infection (i.e., zidovudine [AZT], didanosine [ddI], zalcitabine [ddC], and stavudine [d4T] or certain cancer chemotherapy agents (i.e., ifosfamide, cisplatin) increase the risk of secondary L-carnitine deficiency (135)
Alternative Names: CJC-1295: Mod GRF (1-29), Tetra-substituted GRF (1-29), GHRP-6: Growth Hormone Releasing Peptide-6 CJC-1295 & GHRP-6 Studies and Research Data Research on Pituitary Cell Interactions CJC-1295 has been noted to bind with GHRH receptors in the anterior pituitary, which may contribute to an ongoing pulsatile release of growth hormone
This selectivity has made it a preferred compound for researchers studying isolated growth hormone signalling pathways
10.1016/j.freeradbiomed.2015.12.024 76 PapackovaZ.HeczkovaM.DankovaH.SticovaE.LodererovaA.BartonovaL.et al (2018)
What the 2026 Research Actually Shows A systematic review and meta-analysis published in Cureus in April 2026 pooled data from multiple randomised controlled trials of GLP-1 receptor agonists specifically in women with PMOS
US$ 20.55
US$ 23.17
US$ 27.39
US$ 22.86
US$ 20.40
US$ 25.05
US$ 21.67
